Cargando…

Association of a novel point mutation in MSH2 gene with familial multiple primary cancers

BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hai, Li, Hong, Jiao, Feng, Han, Ting, Zhuo, Meng, Cui, Jiujie, Li, Yixue, Wang, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627420/
https://www.ncbi.nlm.nih.gov/pubmed/28974240
http://dx.doi.org/10.1186/s13045-017-0523-y
_version_ 1783268712193720320
author Hu, Hai
Li, Hong
Jiao, Feng
Han, Ting
Zhuo, Meng
Cui, Jiujie
Li, Yixue
Wang, Liwei
author_facet Hu, Hai
Li, Hong
Jiao, Feng
Han, Ting
Zhuo, Meng
Cui, Jiujie
Li, Yixue
Wang, Liwei
author_sort Hu, Hai
collection PubMed
description BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the risk of many types of cancers. Lynch syndrome patients who suffer more than two cancers can also be considered as MPC; patients of this kind provide unique resources to learn how genetic mutation causes MPC in different tissues. METHODS: We performed a whole genome sequencing on blood cells and two tumor samples of a Lynch syndrome patient who was diagnosed with five primary cancers. The mutational landscape of the tumors, including somatic point mutations and copy number alternations, was characterized. We also compared Lynch syndrome with sporadic cancers and proposed a model to illustrate the mutational process by which Lynch syndrome progresses to MPC. RESULTS: We revealed a novel pathologic mutation on the MSH2 gene (G504 splicing) that associates with Lynch syndrome. Systematical comparison of the mutation landscape revealed that multiple cancers in the proband were evolutionarily independent. Integrative analysis showed that truncating mutations of DNA mismatch repair (MMR) genes were significantly enriched in the patient. A mutation progress model that included germline mutations of MMR genes, double hits of MMR system, mutations in tissue-specific driver genes, and rapid accumulation of additional passenger mutations was proposed to illustrate how MPC occurs in Lynch syndrome patients. CONCLUSION: Our findings demonstrate that both germline and somatic alterations are driving forces of carcinogenesis, which may resolve the carcinogenic theory of Lynch syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-017-0523-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5627420
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56274202017-10-12 Association of a novel point mutation in MSH2 gene with familial multiple primary cancers Hu, Hai Li, Hong Jiao, Feng Han, Ting Zhuo, Meng Cui, Jiujie Li, Yixue Wang, Liwei J Hematol Oncol Research BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the risk of many types of cancers. Lynch syndrome patients who suffer more than two cancers can also be considered as MPC; patients of this kind provide unique resources to learn how genetic mutation causes MPC in different tissues. METHODS: We performed a whole genome sequencing on blood cells and two tumor samples of a Lynch syndrome patient who was diagnosed with five primary cancers. The mutational landscape of the tumors, including somatic point mutations and copy number alternations, was characterized. We also compared Lynch syndrome with sporadic cancers and proposed a model to illustrate the mutational process by which Lynch syndrome progresses to MPC. RESULTS: We revealed a novel pathologic mutation on the MSH2 gene (G504 splicing) that associates with Lynch syndrome. Systematical comparison of the mutation landscape revealed that multiple cancers in the proband were evolutionarily independent. Integrative analysis showed that truncating mutations of DNA mismatch repair (MMR) genes were significantly enriched in the patient. A mutation progress model that included germline mutations of MMR genes, double hits of MMR system, mutations in tissue-specific driver genes, and rapid accumulation of additional passenger mutations was proposed to illustrate how MPC occurs in Lynch syndrome patients. CONCLUSION: Our findings demonstrate that both germline and somatic alterations are driving forces of carcinogenesis, which may resolve the carcinogenic theory of Lynch syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-017-0523-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-03 /pmc/articles/PMC5627420/ /pubmed/28974240 http://dx.doi.org/10.1186/s13045-017-0523-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hu, Hai
Li, Hong
Jiao, Feng
Han, Ting
Zhuo, Meng
Cui, Jiujie
Li, Yixue
Wang, Liwei
Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title_full Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title_fullStr Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title_full_unstemmed Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title_short Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
title_sort association of a novel point mutation in msh2 gene with familial multiple primary cancers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627420/
https://www.ncbi.nlm.nih.gov/pubmed/28974240
http://dx.doi.org/10.1186/s13045-017-0523-y
work_keys_str_mv AT huhai associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT lihong associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT jiaofeng associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT hanting associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT zhuomeng associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT cuijiujie associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT liyixue associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers
AT wangliwei associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers